Join Pharmerit at Pharma Pricing & Market Access Congress 2019, Amsterdam (March 19 – 20, 2019) as we present:
EUnetHTA and Joint Assessments: Focus on the BeNeLuxA Collaboration
Date, Time and Location: Wednesday, 20 March, 2019 at 11:25am, Beurs van Berlage, Amsterdam
Presented by: Rosemary Jose PhD, Director Strategic Market Access
During this session, we will touch upon recent developments in European cross-border collaborations in HTA, focus on some case studies, discuss challenges and the way forward. We will also cover the new dimension of international cross-border collaborations including with non-European agencies, which are currently under discussion, and potential implications for your HTA submissions.
Why you should attend:
- Take a peek into the world of joint clinical assessments
- Be aware of recent developments in HTA cross-border collaboration
- Explore case studies of recent joint assessments across market clusters.
- Gain a real-world update of the ongoing discussions around joint assessments and the way forward
Our other senior colleagues James Eaton, Marja Hensen and Walter Bouwmeester will also be available to speak with you regarding how Pharmerit can support your market access, HEOR and real-world evidence needs, and would be very happy to set up a meeting.